Artelo Biosciences Statistics Share Statistics Artelo Biosciences has 704.42K
shares outstanding. The number of shares has increased by 28.88%
in one year.
Shares Outstanding 704.42K Shares Change (YoY) 28.88% Shares Change (QoQ) 28.86% Owned by Institutions (%) 3.26% Shares Floating 699.97K Failed to Deliver (FTD) Shares 93 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 40.61K, so 2.07% of the outstanding
shares have been sold short.
Short Interest 40.61K Short % of Shares Out 2.07% Short % of Float 2.07% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.09 and the forward
PE ratio is -6.43.
Artelo Biosciences's PEG ratio is
0.73.
PE Ratio -2.09 Forward PE -6.43 PS Ratio 0 Forward PS n/a PB Ratio 7.17 P/FCF Ratio -2.45 PEG Ratio 0.73
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Artelo Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.44,
with a Debt / Equity ratio of 0.04.
Current Ratio 1.44 Quick Ratio 1.44 Debt / Equity 0.04 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.64M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -28.27% in the
last 52 weeks. The beta is 1.41, so Artelo Biosciences's
price volatility has been higher than the market average.
Beta 1.41 52-Week Price Change -28.27% 50-Day Moving Average 8.08 200-Day Moving Average 7.6 Relative Strength Index (RSI) 35.65 Average Volume (20 Days) 266,034
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.11M Net Income -9.83M EBITDA -10.11M EBIT -9.83M Earnings Per Share (EPS) -3.05
Full Income Statement Balance Sheet The company has 2.34M in cash and 104K in
debt, giving a net cash position of 2.23M.
Cash & Cash Equivalents 2.34M Total Debt 104K Net Cash 2.23M Retained Earnings -50.14M Total Assets 4.36M Working Capital -3.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.35M
and capital expenditures 0, giving a free cash flow of -8.35M.
Operating Cash Flow -8.35M Capital Expenditures n/a Free Cash Flow -8.35M FCF Per Share -2.59
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ARTL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ARTL is $30,
which is 522.4% higher than the current price. The consensus rating is "Hold".
Price Target $30 Price Target Difference 522.4% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 13, 2025. It was a
backward
split with a ratio of 1:6.
Last Split Date Jun 13, 2025 Split Type backward Split Ratio 1:6
Scores Altman Z-Score -26.44 Piotroski F-Score 2
